When a patient with Parkinson's disease develops pain, accurately characterising the pain type is a critical first step. This protocol addresses the scenario in which the pain is nociceptive in nature and not neuropathic — a distinction that directly determines the appropriate analgesic strategy.
Parkinson's disease with concurrent nociceptive pain. Neuropathic pain has been excluded as the primary pain mechanism. Management follows a structured, stepwise analgesic framework calibrated to this specific pain type.
Nociceptive pain in this context is addressed according to the WHO analgesic ladder. This protocol operates at the upper tier of that framework — involving high-potency analgesic therapy. The complete regimen, sequencing, and combination approach are detailed in the full protocol.
Full treatment details — including options, combination strategies, and clinical decision points — are available via the link below.